PortView
iShares Neuroscience and Healthcare (IBRN) ETF Holdings & Analysis
ETFOther
What IBRN does
The iShares Neuroscience and Healthcare ETF (IBRN) aims to mirror the financial performance of a particular index. This index consists of companies, both domestically in the U.S. and from other countries, that are expected to benefit from new discoveries and the overall growth in the field of neuroscience.
Fund profile
Top holdings
| Holding | Weight | |
|---|---|---|
| PRAXIS PRECISION MEDICINES | 5.09% | |
| DIANTHUS THERAPEUTICS INC | 4.93% | |
| ACADIA PHARMACEUTICALS | 4.92% | |
| SCHOLAR ROCK HOLDING | 4.89% | |
| ARROWHEAD PHARMACEUTICALS | 4.35% | |
| XENON PHARMACEUTICALS | 4.35% | |
| ARGENX SE ADR | 4.30% | |
| BIOGEN | 4.19% | |
| ALKERMES | 4.15% | |
| PTC THERAPEUTICS | 3.70% |
Sector allocation
| Healthcare | 100.00% |
Geographic allocation
| United States | 73.23% |
| Ireland | 4.59% |
| Canada | 4.35% |
| Netherlands | 4.31% |
| South Korea | 2.62% |
| Sweden | 2.27% |
| Denmark | 1.73% |
| Australia | 1.61% |
| Switzerland | 1.59% |
| Japan | 1.18% |
PortView Portfolio Insights
PortView analyzes how IBRN fits your actual portfolio — position weight, ETF overlap with your other funds, sector and geographic exposure, concentration, and how this fund contributes to your portfolio risk and return. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.
Analyze IBRN in PortView →Related securities
Related stocks
Frequently asked questions
- What does IBRN track?
- IBRN is the iShares Neuroscience and Healthcare ETF, a Other ETF.
- What is the expense ratio of IBRN?
- Expense ratio data for IBRN is shown on the page when available from our data provider.
- What are the largest holdings in IBRN?
- Top holdings include PRAX, DNTH, ACAD, SRRK, ARWR.
- How can PortView analyze IBRN overlap with other ETFs?
- PortView computes the holdings overlap between IBRN and the other ETFs and stocks you own, plus your combined sector and geographic exposure, so you can see true diversification.
The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.